FORM DEF 14A

Company

NovaBay Pharmaceuticals, Inc.

Filed

November 12, 2021

Period of Report

December 17, 2021

Accession Number

0001437749-21-026317

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →